title: Future therapies: Early trials and basic science.
abstract: Pharmacotherapeutic options for overactive bladder (OAB) include antimuscarinics and the beta3-adrenoceptor agonist mirabegron. Research and development of novel therapeutic options for OAB continues to be an active field. This review summarizes recent research with the existing therapies as well as the most promising agents in development.
authors: Professor, Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC.
authors: Karl-Erik
authors: KE
authors: Andersson